Base year - blood bank reagents, etc.

Ended Purchase Order Awarded Last action

Contract number
W91YTZ19P0421
Awardee
Awarding agency
Obligated
$593,524

Award facts

Opportunity
Contract value 100% obligated
$593,524.45 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
Contracting staff
Set-aside
No set-aside
Competition
Full and Open Competition · 1 offer Negotiated Proposal / Quote
Pricing
Firm Fixed Price
Place of performance
Fort Stewart, GA, USA

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Funding Only Action P00013 · Option year 2 - blood bank reagents, etc -$2,128
Funding Only Action P00012 · FY21-FY23 deob blood bank reagents -$15,070
Funding Only Action P00011 · MOD fund FY24 $123,744
Exercise an Option P00010 · SAF FY24 OY4 blood bank reagents $0
Funding Only Action P00009 · MOD fund FY23 $123,744
Exercise an Option P00008 · MOD - OPT FY23 ortho clinical W91YTZ19P0421 $0
Other Administrative Action P00007 · Admin MOD PD2 error correction only $0
Funding Only Action P00006 · FY22 MOD fund ortho clinical W91YTZ19P0421 1161418 $123,744
Exercise an Option P00005 · FY22 winn ortho YR 2 PR 0011614418 $0
Funding Only Action P00004 · ROF FY21 and sect 889 $123,744
Exercise an Option P00003 · Option year 1 - blood bank reagents, etc $0
Funding Only Action P00002 -$8,000
Funding Only Action P00001 $123,744
Original award $0
Show all 14

About this award

Ortho-Clinical Diagnostics, Inc., a for-profit medical equipment manufacturer headquartered in Raritan, New Jersey, was awarded a firm fixed-price purchase order by the Medical Command (Defense) on October 1, 2019, for blood bank reagents and related supplies. The contract, which carries a ceiling value of $593,524.45 and was executed at Fort Stewart, Georgia, encompasses a base year and an option year 2 period, with an ultimate completion date of September 30, 2024. This award was issued without a set-aside designation, indicating open competition, and follows a solicitation posted on September 16, 2019, with a due date of September 20, 2019.

Ortho-Clinical Diagnostics specializes in providing critical laboratory diagnostic infrastructure to federal healthcare agencies, including blood bank analyzers, clinical chemistry systems, and consumables. The company maintains multiple significant indefinite delivery vehicles across the federal healthcare system, including blanket purchase agreements with the Department of Veterans Affairs and Indian Health Service. This contract aligns with the company's core business of supplying blood bank reagents and associated technical services to federal military medical facilities and represents a continuation of the vendor's established role in supporting federal healthcare operations through specialized diagnostic consumables and equipment support.

Quick answers

Who was awarded contract W91YTZ19P0421?

W91YTZ19P0421 was awarded to Ortho-Clinical Diagnostics, Inc. by Medical Command (Department of the Army) on October 1, 2019.

How much is contract W91YTZ19P0421 worth?

The government has obligated $593,524 on W91YTZ19P0421.

Was contract W91YTZ19P0421 competed?

The extent of competition for W91YTZ19P0421 was full and open competition. The government received 1 offer.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award